ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,008Medicare Part D Prescriptions Filled, Including Refills

Rank: 78 out of 252

$505K Total Retail Price of All Prescriptions

Rank: 97 out of 252

397 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 397 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 397 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 9,583 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
OMEPRAZOLE 493 449 1 6
LEVOTHYROXINE SODIUM 360 297 2 1
HYDROCODONE-ACETAMINOPHEN 337 277 S3 3 5
POTASSIUM CHLORIDE 322 289 4 8
METOPROLOL TARTRATE 299 285 5 10
SIMVASTATIN 299 262 5 2
AMLODIPINE BESYLATE 260 242 7 4
WARFARIN SODIUM 257 248 8 14
PRAVASTATIN SODIUM 235 189 9 12
ZOLPIDEM TARTRATE 201 161 10 21
BUMETANIDE 201 179 10 139
LISINOPRIL 183 161 12 3
AZITHROMYCIN 181 150 13 37
ATORVASTATIN CALCIUM 173 170 14 16
FUROSEMIDE 170 157 15 7
DOXAZOSIN MESYLATE 165 145 16 73
METFORMIN HCL 162 139 17 9
ESCITALOPRAM OXALATE 151 132 18 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 139 131 19 25
GABAPENTIN 139 109 19 11
MELOXICAM 136 108 21 20
CRESTOR 126 124 22 34
TRAMADOL HCL 126 86 22 17
DIOVAN HCT 124 110 24 65
TIZANIDINE HCL 119 69 25 129
ATENOLOL 117 105 26 18
NEXIUM 101 84 27 23
ESTRADIOL 99 78 R 28 76
CLOPIDOGREL 99 99 28 29
METOPROLOL SUCCINATE 95 79 30 19
AMLODIPINE BESYLATE-BENAZEPRIL 93 93 31 60
SERTRALINE HCL 92 75 32 27
LOSARTAN-HYDROCHLOROTHIAZIDE 90 89 33 49
DIGOXIN 87 82 34 44
LOSARTAN POTASSIUM 86 67 35 24
TRIAMTERENE-HYDROCHLOROTHIAZID 85 78 36 134
CITALOPRAM HBR 84 73 37 15
PROPAFENONE HCL 77 77 38 221
SUCRALFATE 77 71 38 125
ALLOPURINOL 76 68 40 30
POLYETHYLENE GLYCOL 3350 75 66 41 67
LYRICA 68 42 42 66
FLUOXETINE HCL 68 52 42 57
PREDNISONE 66 54 44 42
FLUTICASONE PROPIONATE 66 61 44 36
PANTOPRAZOLE SODIUM 64 58 46 62
VOLTAREN 64 53 46 236
DIOVAN 64 64 46 38
CYMBALTA 63 17 49 45
TRICOR 63 51 49 145
FLUCONAZOLE 63 53 49 185
PLAVIX 63 63 49 43
PREMARIN 61 23 R 53 116
NADOLOL 61 52 53 207
SYNTHROID 60 60 55 47
CIPROFLOXACIN HCL 59 54 56 61
HYDROCHLOROTHIAZIDE 58 55 57 13
TAMSULOSIN HCL 58 48 57 26
ALENDRONATE SODIUM 58 58 57 32
TRIAMTERENE-HCTZ 58 47 57 33
GLIPIZIDE 52 52 61 52
AMOX TR-POTASSIUM CLAVULANATE 51 39 62 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.